Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/288791
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Behavioural and functional characterization of Kν10.1 (Eag1) knockout mice

AutorUfartes, Roser; Schneider, Tomasz; Sünke Mortensen, Lena; Juan Romero, Camino de CSIC ORCID; Hentrich, Klaus; Knoetgen, Hendrik; Beilinson, Vadim; Moebius, Wiebke; Tarabykin, Victor; Alves, Frauke; Pardo, Luis A.; Rawlins, J. Nicholas P.; Stuehmer, Walter
Fecha de publicación2013
EditorOxford University Press
CitaciónHuman Molecular Genetics 22(11): 2247-2262 (2013)
ResumenKv10.1 (Eag1), member of the Kv10 family of voltage-gated potassium channels, is preferentially expressed in adult brain. The aim of the present study was to unravel the functional role of Kv10.1 in the brain by generating knockout mice, where the voltage sensor and pore region of Kv10.1 were removed to render non-functional proteins through deletion of exon 7 of the KCNH1 gene using the ‘3 Lox P strategy’. Kv10.1-deficient mice show no obvious alterations during embryogenesis and develop normally to adulthood; cortex, hippocampus and cerebellum appear anatomically normal. Other tests, including general health screen, sensorimotor functioning and gating, anxiety, social behaviour, learning and memory did not show any functional aberrations in Kv10.1 null mice. Kv10.1 null mice display mild hyperactivity and longer-lasting haloperidol-induced catalepsy, but there was no difference between genotypes in amphetamine sensitization and withdrawal, reactivity to apomorphine and haloperidol in the prepulse inhibition tests or to antidepressants in the haloperidol-induced catalepsy. Furthermore, electrical properties of Kv10.1 in cerebellar Purkinje cells did not show any difference between genotypes. Bearing in mind that Kv10.1 is overexpressed in over 70% of all human tumours and that its inhibition leads to a reduced tumour cell proliferation, the fact that deletion of Kv10.1 does not show a marked phenotype is a prerequisite for utilizing Kv10.1 blocking and/or reduction techniques, such as siRNA, to treat cancer.
Versión del editorhttps://doi.org/10.1093/hmg/ddt076
URIhttp://hdl.handle.net/10261/288791
DOI10.1093/hmg/ddt076
ISSN0964-6906
Aparece en las colecciones: (IN) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Eag1.pdf785,54 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

24
checked on 19-may-2024

SCOPUSTM   
Citations

44
checked on 19-may-2024

WEB OF SCIENCETM
Citations

40
checked on 29-feb-2024

Page view(s)

21
checked on 21-may-2024

Download(s)

13
checked on 21-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons